Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Salmi, A.
Right arrow Articles by Reunanen, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salmi, A.
Right arrow Articles by Reunanen, M.
NEUROLOGY 1982;32:292
© 1982 American Academy of Neurology

Antibodies to coronaviruses OC43 and 229E in multiple sclerosis patients

Aimo Salmi, M.D., Ph.D., Barry Ziola, Ph. D., Tapani Hovi, M.D., Ph.D. and Mauri Reunanen, M.D.

Neurovirology Study Group, Department of Virology (Drs. Salmi and Ziola), University of Turku, Turku, the Department of Virology (Dr. Hovi), University of Helsinki, Helsinki, and the Department of Neurology (Dr. Reunanen), University of Oulu, Oulu, Finland.

Multiple sclerosis (MS) and matched control sera had similar antibody titers to coronaviruses OC43 and 229E when tested by a radioimmunoassay method. In contrast, cerebrospinal fluid from MS patients contained coronavirus antibodies more frequently and in higher titers than matched controls. Intrathecal antibody synthesis to OC43 and 229E viruses was detected in 41% (9/22) and 26% (7/27) of MS patients, respectively, but was not found in any of the neurologic control patients. This intrathecal antibody synthesis may mean that coronaviruses play an etiologic or pathogenic role in MS. Alternatively, intrathecal synthesis of coronavirus antibodies may be but part of a generalized and variable intrathecal antibody synthesis that is typical for MS patients.

Address correspondence and reprint requests to Dr. Salmi, The Neurovirology Study Group, Department of Virology, University of Turku, Kiinamyllynkatu 10, 20520 Turku 52, Finland.

This research was supported by the Sigrid Jusélius Foundation and the Academy of Finland, Medical Research Council. Dr. Ziola was the recipient of a Centennial Fellowship from the Medical Research Council of Canada.

Accepted for publication August 13, 1981.




This article has been cited by other articles:


Home page
J. Virol.Home page
N. Arbour, R. Day, J. Newcombe, and P. J. Talbot
Neuroinvasion by Human Respiratory Coronaviruses
J. Virol., October 1, 2000; 74(19): 8913 - 8921.
[Abstract] [Full Text]


Home page
J. Virol.Home page
N. Arbour, S. Ekandé, G. Côté, C. Lachance, F. Chagnon, M. Tardieu, N. R. Cashman, and P. J. Talbot
Persistent Infection of Human Oligodendrocytic and Neuroglial Cell Lines by Human Coronavirus 229E
J. Virol., April 1, 1999; 73(4): 3326 - 3337.
[Abstract] [Full Text]


Home page
J. Virol.Home page
N. Arbour, G. Côté, C. Lachance, M. Tardieu, N. R. Cashman, and P. J. Talbot
Acute and Persistent Infection of Human Neural Cell Lines by Human Coronavirus OC43
J. Virol., April 1, 1999; 73(4): 3338 - 3350.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by AAN Enterprises, Inc.